S Studi Farmakovigilans Vaksinasi Booster Covid-19 Pada Masyarakat Di Desa Pujon Kalimantan Tengah: Studi Farmakovigilans Vaksinasi Booster Covid-19 Pada Masyarakat Di Desa Pujon Kalimantan Tengah

Devi Norlita; Iwan Yuwindry; Saftia Aryzki; Melviani Melviani

doi:10.33859/jpcs.v5i1.648

Authors

Devi Norlita Universitas Sari Mulia Banjarmasin
Iwan Yuwindry Sari Mulia University
Saftia Aryzki Sari Mulia University
Melviani Melviani Sari Mulia University

DOI:

https://doi.org/10.33859/jpcs.v5i1.648

Keywords:

Covid-19, Pharmacovigilance, Booster Vaccine

Abstract

Background: Covid-19 booster vaccination is expected to achieve herd immunity (group immunity) forming antibodies or strong immunity so that people can survive the Covid-19 virus and hopefully the Covid-19 pandemic will turn into a Covid-19 epidemic. Adverse Drug Reactions (ROM) are unwanted side effects of a drug that arise when administering the drug at a dose used for prophylaxis, diagnosis, and therapy that is actual or potential.
Objective: To determine the Pharmacovigilance Study of Covid-19 booster vaccination in the Pujon Village community, Central Kalimantan.
Method: This study is Observational in nature, Quantitative. with a descriptive research method, the approach used in this study is cross-sectional. The study was conducted in July in the Pujon Village environment, Central Kalimantan.
Results: From the side effects of the Covid-19 booster vaccination, namely the results of the Naranjo Algorithm measurement, it is known that out of 98 respondents, the Pujon village community received the most results in the Naranjo Probable category, which is a side effect of the Covid-19 vaccination, with 20 respondents (20.41%). It is known that there were 55 respondents who experienced possible side effects. Among them, 25 had fever and 30 had pain after receiving the Covid-19 vaccination.
Conclusion: From the side effects of the Covid-19 booster vaccination, namely the results of the Naranjo Algorithm measurement, it is known that out of 98 respondents, the Pujon village community received the most results in the Naranjo Possible category, which is a possible side effect of the Covid-19 vaccination, with 55 respondents (56.12%). It is known that there were 55 respondents who experienced possible definite side effects. Among them, 25 had fever and 30 had pain after receiving the Covid-19 vaccination

References

Abraham, N., Spruin, S., Rossi, T., Fireman, B., Zafack, J., Blaser, C., Shaw, A., Hutchings, K., & Ogunnaike-Cooke, S. (2022). Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines. Vaccine, 40(32), 4663–4671. https://doi.org/10.1016/j.vaccine.2022.05.048

Adiputra, M. S., Trisnadewi, N. W., & Oktaviani, P. W. (2021). Metodologi Penelitian Kesehatan. In Angewandte Chemie International Edition, 6(11), 951–952.

Andrea Ossato et al. (2021). Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021. European Journal Of Hospital Pharmacy, 30(4). https://doi.org/http://dx.doi.org/10.1136/ejhpharm-2021-002933

Hafizzanovian, H., Oktariana, D., Apriansyah, M. A., & Yuniza, Y. (2021). Peluang Terjadinya Immunization Stress-Related Response (Isrr) Selama Program Vaksinasi Covid-19. Jurnal Kedokteran Dan Kesehatan Publikasi Ilmiah Fakultas Kedokteran Universitas Sriwijaya, 8(3), 211–222. https://doi.org/10.32539/jkk.v8i3.13807

Helmi et al. (2020). EUTRALIZING ANTIBODY TERJADI PADA MANUSIA DARI VIRUS SARS-COV-2 AKIBAT VAKSIN YANG BEREDAR DI INDONESIA. Farmaka, 18(1), 1–15.

Liu, Z., VanBlargan, L. A., Bloyet, L. M., Rothlauf, P. W., Chen, R. E., Stumpf, S., Zhao, H., Errico, J. M., Theel, E. S., Liebeskind, M. J., Alford, B., Buchser, W. J., Ellebedy, A. H., Fremont, D. H., Diamond, M. S., & Whelan, S. P. J. (2021). Identification of SARS-CoV-2 Spike Mutations That Attenuate Monoclonal and Serum Antibody Neutralization. Cell Host and Microbe, 29(3), 477-488.e4. https://doi.org/10.1016/j.chom.2021.01.014

Platto, S., Xue, T., & Carafoli, E. (2020). COVID19: an announced pandemic. Cell Death and Disease, 11(9). https://doi.org/10.1038/s41419-020-02995-9

Syahadati, N., Shanti, N., Erta, Shinta, H., & Nurhasan. (2021). Efek Samping dan Reaktogenisitas Vaksin COVID-19: Survei Penerima Vaksin. Jurnal Ilmiah Indonesia, 6(2), 2013–2015.

Yulyani, V., Hasbie, N. F., Farich, A., & Valentine, A. (2022). Hubungan Status Demografi, Komorbid Dengan KIPI Post Vaksin COVID-19 Pada Tenaga Kesehatan. Jurnal Ilmiah Kesehatan Sandi Husada, 11, 153–160. https://doi.org/10.35816/jiskh.v11i1.725

Light, M. A., & Light, I. H. (2008). The geographic expansion of Mexican immigration in the United States and its implications for local law enforcement. Law Enforcement Executive Forum Journal, 8(1), 73-82.